Keeping a Mounjaro journal: what to record and why it matters

The biggest myth: that journalling is just about tracking weight

A lot of people come to the idea of a Mounjaro journal thinking mainly about the scales. They plan to log their weekly weight, see the number fall, feel motivated. That is not wrong, but it misses most of what a journal is for. Weight on tirzepatide can plateau for two or three weeks at a time even when the medicine is working exactly as it should, something the NHS tirzepatide guidance reflects when it notes that results take time and vary between individuals. If your only data point is the scale, a plateau looks like failure. If you also have notes on how much less you wanted to eat at lunch, how a walk felt easier, or how the nausea you felt in week two has now gone, the picture changes. The journal becomes evidence that things are happening, even when the number is not moving yet.

Clinical trials of tirzepatide (including SURMOUNT-1, published in the New England Journal of Medicine) ran for 72 weeks. That is a long arc. Expecting linear week-by-week weight loss across that arc misunderstands how the medicine works biologically, and if you want a clearer overview of how Mounjaro fits into a broader weight management plan, our dedicated page covers everything from how it works to who it is suitable for. Recording more than the scale is the practical answer to that misunderstanding.

What a useful Mounjaro journal actually contains

There is no prescribed format, and complexity is not the goal. The entries that prove most useful tend to cluster around five things. First, the injection itself: the date, the dose, and the site you used (abdomen, thigh or upper arm, rotated each week). This matters if you later notice injection-site reactions and want to see whether they follow a pattern. Second, appetite and fullness: a brief note after meals on how hungry you actually felt beforehand and how quickly you reached a point of comfortable fullness. Third, any side effects (nausea, loose stools, constipation, reflux) noted with a rough severity and time of day. Fourth, energy and mood, even one word per day. Fifth, practical observations about your routine: what you ate, how much water you drank, whether you moved more or less than usual.

People on tirzepatide often find that the drop in appetite is most noticeable in the days after an injection and then softens slightly by day six or seven. That rhythm, once you see it written across a few weeks, is something you can actually plan around. It is also the kind of observation that helps a prescriber understand how the current dose is landing. You can read more about the treatment journey itself on the Mounjaro weight-loss journey page, which covers the longer arc from first pen to maintenance.

Side effects, dose increases and the prescriber conversation

Gastrointestinal side effects are the most commonly reported experience on tirzepatide: nausea, loose stools, constipation, reflux and burping, especially in the early weeks or after a step up in dose. Most people find they settle within days to a couple of weeks. A journal is valuable here precisely because memory is unreliable about severity and timing. If you noted "mild nausea, two hours after injection, gone by evening" on four consecutive weeks and then nothing in week five, you have useful information. If you noted "severe nausea, lasted three days" on the same date each month, that is a different story and worth raising, and those patterns can be particularly important when you are considering whether to move up, as our Mounjaro 2 page explains what the step up to the next strength typically involves.

One side effect to be aware of, separate from the GI profile, is severe stomach pain that spreads to the back, with or without vomiting. The MHRA highlighted acute pancreatitis as an infrequent but serious known risk for GLP-1 medicines in a Drug Safety Update published in January 2026. Do not rely on your journal in that situation, get medical help promptly. For everything else, the record you keep will make dose-review conversations more specific and easier to act on.

If you are thinking about what treatment costs and whether it fits alongside a journal-supported approach, the Mounjaro cost page explains what a transparent private price typically covers.

Nutrition, vitamins and the journal's practical edge

Because tirzepatide reduces appetite significantly, some people find they are eating far less than they realise, not just less in calories but less in protein, fibre and micronutrients. A journal that includes a rough food note (not a full calorie count, just a description) can flag this before it becomes a problem. Low protein intake in particular can mean that weight lost includes more lean mass than it should, and this consideration becomes especially relevant for people who have progressed to a higher strength, so the Mounjaro 5 page is worth reading for guidance on what to expect at that stage. This is one reason our prescribers often discuss nutrition alongside dose decisions.

The vitamins and Mounjaro page goes into more detail on micronutrients worth keeping an eye on during treatment. Deficiencies in vitamin D, vitamin B12 and iron can all manifest as fatigue, and fatigue is also a common early side effect of tirzepatide itself. Without a journal, it is genuinely hard to tell which is driving a dip in energy. With one, patterns across weeks become visible. That is the practical edge a record offers, not motivation through visible progress, though that helps too, but real clinical signal that your prescribing team can use.

If you have questions about how treatment at nume works from a clinical oversight perspective, our clinical team page and about us page explain who reviews consultations and how. When you are ready to take the next step, start your free consultation, a GPhC-registered prescriber, not an algorithm, reads every submission the same day.